Mother and Child: Medication Use in Pregnancy and Lactation

2016 ◽  
Vol 100 (1) ◽  
pp. 8-11 ◽  
Author(s):  
S Ito
Keyword(s):  
Medication Use ◽  
Mother And Child ◽  
Pregnancy And Lactation ◽  
In Pregnancy

Medication use in pregnancy and lactation: A gap to be filled in postgraduate medical education

2021 ◽  
Vol 260 ◽  
pp. 52-55
Author(s):  
Claire M. McCarthy ◽  
Fergal O’Shaughnessy ◽  
Nicola Maher ◽  
Brian J. Cleary ◽  
Jennifer C. Donnelly
Keyword(s):  
Medical Education ◽  
Postgraduate Medical Education ◽  
Medication Use ◽  
Pregnancy And Lactation ◽  
In Pregnancy

scholarly journals Evaluating Medication Use in Pregnancy and Lactation: What Every Pharmacist Should Know

2013 ◽  
Vol 18 (3) ◽  
pp. 247-258 ◽  
Author(s):  
Betsy Walters Burkey ◽  
Amy P. Holmes
Keyword(s):  
Breast Milk ◽  
Drug Administration ◽  
Rating Scales ◽  
Food And Drug Administration ◽  
Medication Use ◽  
Drug Transfer ◽  
Drug Classes ◽  
Pregnancy And Lactation ◽  
In Pregnancy

As a pharmacist, being asked to give advice about medication use during pregnancy or lactation can be daunting. This article reviews the principles of drug transfer across the placenta, into breast milk, and reviews the rating scales and different resources available. The Food and Drug Administration classification scale is reviewed and the upcoming changes are explained, along with recent labeling changes for specific medications or drug classes when appropriate. This article provides the pharmacist with a practical set of tools to review the information available and assess the risks of treating or withholding a medication for mother and infant.

Medication use in pregnancy and the pregnancy and lactation labeling rule

2016 ◽  
Vol 100 (1) ◽  
pp. 23-25 ◽  
Author(s):  
L Sahin ◽  
SC Nallani ◽  
MS Tassinari
Keyword(s):  
Medication Use ◽  
Pregnancy And Lactation ◽  
In Pregnancy

scholarly journals A pharmacometrician’s role in enhancing medication use in pregnancy and lactation

2020 ◽  
Vol 47 (4) ◽  
pp. 267-269
Author(s):  
Sara K. Quinney ◽  
Peter L. Bonate
Keyword(s):  
Medication Use ◽  
Pregnancy And Lactation ◽  
In Pregnancy

Guide for Drug Selection During Pregnancy and Lactation: What Pharmacists Need to Know for Current Practice

2018 ◽  
Vol 52 (8) ◽  
pp. 810-818 ◽  
Author(s):  
Brooke L. Griffin ◽  
Rebecca H. Stone ◽  
Shareen Y. El-Ibiary ◽  
Sarah Westberg ◽  
Kayce Shealy ◽  
...  
Keyword(s):  
Risk Assessment ◽  
Chronic Disease ◽  
Fetal Development ◽  
Chronic Conditions ◽  
Medication Use ◽  
Care Providers ◽  
Drug Transfer ◽  
Pregnancy And Lactation ◽  
Trimester Exposure ◽  
In Pregnancy

Objective: To provide guidance for clinicians on risk assessment of medication use during pregnancy and lactation. Data Sources: Authors completed PubMed searches to identify articles focused on the use of medications in pregnancy, including fetal development, drug transfer across the placenta, trimester exposure, chronic conditions in pregnancy, medications in lactation, and lactation and chronic disease. Study Selection and Data Extraction: Articles were reviewed to provide overall guidance to medication selection during pregnancy. The following information was reviewed: medication use in pregnancy, including fetal development, drug transfer across the placenta, trimester exposure, chronic conditions in pregnancy, medications in lactation, and lactation and chronic disease. Data Synthesis: This article will provide an overview of medication safety considerations during pregnancy and lactation. Information was interpreted to help clinicians predict the potential risk and benefit in each patient to make an evidence-based decision. The article concludes with guidance on risk assessment and how pharmacists may support fellow health care providers and their patients when considering medication use. Conclusions: Information about the effects of medication use during reproductive periods is limited. With the removal of the Food and Drug Administration pregnancy categories, clinicians will be relying on pharmacists to aid in the appropriate selection of therapies for patients. It is critical that pharmacists keep abreast of resources available and be able to assess data to help prescribers and their patients.

THIOURACIL TREATMENT IN PREGNANCY AND LACTATION IN THE DOG

1962 ◽  
Vol 40 (3) ◽  
pp. 430-440 ◽  
Author(s):  
K. E. Arosenius ◽  
H. Derblom ◽  
G. Nylander
Keyword(s):  
Thyroid Gland ◽  
List Type ◽  
Histological Changes ◽  
Morphological Effect ◽  
Iodine Metabolism ◽  
Pregnancy And Lactation ◽  
In Pregnancy

ABSTRACT The offspring of bitches treated with thiouracil during pregnancy and lactation were studied with regard to certain aspects of iodine metabolism and also to the morphological effect on the thyroid gland, as compared with controls of the same age and weight. At the age of six months, when the dogs were virtually fully grown, the thyroid gland still exhibited the effects of the thiouracil treatment of the mothers as manifested by an increased uptake of 131I, enlargement, and histological changes of a hyperplastic type. The significance of these deviations from normal iodine metabolism and morphology is discussed with particular reference to the dangers of thiouracil medication during pregnancy.

A systematic review of the use of prazosin in pregnancy and lactation

2021 ◽  
Author(s):  
Ashley D. Davidson ◽  
Amritha Bhat ◽  
Frances Chu ◽  
Jessie N. Rice ◽  
N. Aba Nduom ◽  
...  
Keyword(s):  
Systematic Review ◽  
Pregnancy And Lactation ◽  
In Pregnancy

scholarly journals Treatment and therapeutic strategies for pituitary apoplexy in pregnancy: a case series

2021 ◽  
Vol 15 (1) ◽  
Author(s):  
Yuya Kato ◽  
Yoshikazu Ogawa ◽  
Teiji Tominaga
Keyword(s):  
Pituitary Apoplexy ◽  
Clinical Symptoms ◽  
Case Series ◽  
Optimal Timing ◽  
Presenting Symptoms ◽  
Pathological Evaluation ◽  
Mother And Child ◽  
Life Threatening ◽  
In Pregnancy

Abstract Background Pregnancy is a known risk factor for pituitary apoplexy, which is life threatening for both mother and child. However, very few clinical interventions have been proposed for managing pituitary apoplexy in pregnancy. Case presentation We describe the management of three cases of pituitary apoplexy during pregnancy and review available literature. Presenting symptoms in our case series were headache and/or visual disturbances, and the etiology in all cases was hemorrhage. Conservative therapy was followed until 34 weeks of gestation, after which babies were delivered by cesarean section with prophylactic bolus hydrocortisone supplementation. Tumor removal was only electively performed after delivery using the transsphenoidal approach. All three patients and their babies had a good clinical course, and postoperative pathological evaluation revealed that all tumors were functional and that they secreted prolactin. Conclusions Although the mechanism of pituitary apoplexy occurrence remains unknown, the most important treatment strategy for pituitary apoplexy in pregnancy remains adequate hydrocortisone supplementation and frequent hormonal investigation. Radiological follow-up should be performed only if clinical symptoms deteriorate, and optimal timing for surgical resection should be discussed by a multidisciplinary team that includes obstetricians and neonatologists.

Sign in / Sign up

Export Citation Format

Share Document